The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment

1994 ◽  
Vol 56 (2) ◽  
pp. 229-234 ◽  
Author(s):  
Bruce A Sussex ◽  
Norman R C Campbell ◽  
Mahesh K Raju ◽  
Donald W Mckay
1997 ◽  
Vol 13 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Andreas P. Michaelides ◽  
Konstantinos Spiropoulos ◽  
Konstantinos Dimopoulos ◽  
Demetrios Athanasiades ◽  
Pavlos Toutouzas

CHEST Journal ◽  
1978 ◽  
Vol 73 (3) ◽  
pp. 327-332 ◽  
Author(s):  
Garrett Lee ◽  
Dean T. Mason ◽  
Ezra A. Amsterdam ◽  
Richard R. Miller ◽  
Anthony N. DeMaria

2019 ◽  
Vol 28 (3) ◽  
pp. 548-552
Author(s):  
Andro Košec ◽  
Ivan Kruljac ◽  
Jakov Ajduk

Objective Current recommendations for cochlear hydrops treatment include systemic glucocorticoids and diuretics. Cochlear cells express dopamine receptors, although their role is unknown in the pathophysiology of cochlear hydrops. Case Description We report the case of remission of recurrent right-sided cochlear hydrops in a young male patient treated with bromocriptine due to pituitary macroprolactinoma. Transient improvement was observed after oral steroid and diuretic treatment, but cochlear hydrops recurred until the dose of bromocriptine was increased to 10 mg daily. Conclusion Bromocriptine may stimulate dopamine receptors in cochlear cells with potential therapeutic role in patients with cochlear hydrops. There are no widely accepted and effective treatments for endolymphatic hydrops, and identifying potential new and efficacious therapeutics is of high relevance.


Author(s):  
Elena Rodríguez-Sánchez ◽  
José Alberto Navarro-García ◽  
Jennifer Aceves-Ripoll ◽  
Laura González-Lafuente ◽  
Nerea Corbacho-Alonso ◽  
...  

Abstract Aging and chronic kidney disease (CKD) are important interrelated cardiovascular risk (CVR) factors linked to oxidative stress, but this relationship has not been well studied in older adults. We assessed the global oxidative status in an older population with normal to severely impaired renal function. We determined the oxidative status of 93 older adults (mean age 85 years) using multimarker scores. OxyScore was computed as index of systemic oxidative damage by analyzing carbonyl groups, oxidized low-density lipoprotein, 8-hydroxy-2′-deoxyguanosine, and xanthine oxidase activity. AntioxyScore was computed as index of antioxidant defense by analyzing catalase and superoxide dismutase (SOD) activity and total antioxidant capacity. OxyScore and AntioxyScore were higher in subjects with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 than in peers with eGFR >60 mL/min/1.73 m2, with protein carbonyls, catalase, and SOD activity as major drivers. Older adults with a recent cardiovascular event had similar OxyScore and AntioxyScore as peers with eGFR >60 mL/min/1.73 m2. Multivariate linear regression analysis revealed that both indices were associated with decreased eGFR independently of traditional CVR factors. Interestingly, AntioxyScore was also associated with diuretic treatment, and a more pronounced increase was seen in subjects receiving combination therapy. The associations of AntioxyScore with diuretic treatment and eGFR were mutually independent. In conclusion, eGFR is the major contributor to the imbalance in oxidative stress in this older population. Given the association between oxidative stress, CKD, and CVR, the inclusion of renal function parameters in CVR estimators for older populations, such as the SCORE-OP, might improve their modest performance.


2005 ◽  
Vol 39 (6) ◽  
pp. 474-478 ◽  
Author(s):  
Tryggve Nevéus ◽  
Eva Johansson ◽  
Kerstin Nydahl-Persson ◽  
Hans Peterson ◽  
Sverker Hansson

Sign in / Sign up

Export Citation Format

Share Document